rethinkTHC Search
Menu
Study breakdown

Cannabis users show higher schizotypy traits and aberrant salience but normal salience processing on lab tasks

Cross SectionalModerate evidence
The takeaway

Among 346 university students, current cannabis users reported higher schizotypy traits and more aberrant salience experiences on self-report measures, but did not show impaired salience processing on an objective laboratory task.

Psychosis researchers, cognitive neuroscientists, and clinicians interested in cannabis-psychosis mechanisms.

Higher subjective aberrant salience but normal objective salience processing

What the researchers found

Current cannabis use was associated with higher "disorganized" and "cognitive-perceptual" schizotypy scores and higher aberrant salience inventory scores. However, neither lifetime nor current cannabis use was associated with abnormal latent inhibition (LI), an objective measure of salience processing. Higher scores on specific aberrant salience subscales ("senses sharpening" and "heightened cognition") did predict decreased LI, regardless of cannabis use.

Why it matters

The disconnect between self-reported aberrant salience (which is higher in cannabis users) and objective salience processing (which is normal) helps clarify the mechanism by which cannabis might increase psychosis risk.

The numbers in context

346 participants. Cannabis users had higher disorganized and cognitive-perceptual SPQ scores and higher total ASI scores. No association between cannabis use and LI performance.

How the study worked

Cross-sectional study of 346 university students who completed the Schizotypal Personality Questionnaire, Aberrant Salience Inventory, Cannabis Experience Questionnaire, and a latent inhibition task. Regression models and Bayesian analyses used.

What this study cannot tell us

Non-clinical university sample. Cross-sectional design. Self-reported cannabis use. LI task may lack sensitivity for detecting subtle impairments. Cannot distinguish acute from chronic cannabis effects.

How to read the evidence

Well-designed cross-sectional study with both subjective and objective measures, but non-clinical sample limits generalizability.

When this study was published

Published in 2022.

The bigger picture

The finding that subjective aberrant salience experiences increase with cannabis use but objective salience processing remains intact in non-clinical populations suggests that cannabis may shift perception and interpretation without fundamentally disrupting the underlying cognitive mechanism.

Questions still open

  • Would heavier cannabis users or clinical populations show LI impairments? Does the increased subjective aberrant salience represent a preclinical stage of psychosis risk? Could acute intoxication produce different results?

Common questions

Do cannabis users process information differently?
Cannabis users in this study reported more experiences of aberrant salience (attributing unusual significance to stimuli) on self-report measures, but performed normally on an objective laboratory measure of salience processing.
What does this mean for psychosis risk?
The gap between subjective experience and objective performance suggests cannabis may change how people interpret their experiences without fundamentally disrupting the underlying cognitive machinery, at least in non-clinical populations.

Read the original research

Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.

Schizophrenia research. Cognition, 28, 100235

Citation

Dawes, Christopher; Quinn, Declan; Bickerdike, Andrea; O'Neill, Cian; Granger, Kiri T; Pereira, Sarah Carneiro; Mah, Sue Lynn; Haselgrove, Mark; Waddington, John L; O'Tuathaigh, Colm; Moran, Paula M. (2022). Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.. Schizophrenia research. Cognition, 28, 100235. https://doi.org/10.1016/j.scog.2021.100235

Explore the wider topic